Blue Earth Diagnostics is backed by Syncona. Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Syncona’s vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
Syncona seeks to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. It takes a long-term view, underpinned by a deep pool of capital, and is an established leader in cell therapy, gene therapy and advanced diagnostics. Through its portfolio of nine life science companies it focuses on delivering dramatic efficacy for patients in areas of high unmet need.